Showing 1 - 5 results of 5 for search 'Alexis Ogdie', query time: 0.02s Refine Results
  1. 1
    A Response to: Letter to the Editor Regarding Impact of Race on the Efficacy and Safety of Tofacitinib in Rheumatoid Arthritis: Post Hoc Analysis of Pooled Clinical Trials

    A Response to: Letter to the Editor Regarding Impact of Race on the Efficacy and Safety of Tofacitinib in Rheumatoid Arthritis: Post Hoc Analysis of Pooled Clinical Trials by Grace C. Wright, Eduardo Mysler, Arne Yndestad, Cassandra D. Kinch, Alexis Ogdie

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Impact of Delay of Treatment With Disease‐Modifying Antirheumatic Drugs in Psoriatic Arthritis: The CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry

    Impact of Delay of Treatment With Disease‐Modifying Antirheumatic Drugs in Psoriatic Arthritis: The CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry by Philip J. Mease, Miroslawa Nowak, Jiyoon Choi, Thomas Lehman, Antoine Sreih, Kaylee Ho, Nicole Middaugh, Alexis Ogdie

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Validity and score interpretation of the 12-item Psoriatic Arthritis Impact of Disease: an analysis of pooled data from two phase 3 trials of bimekizumab in patients with psoriatic arthritis

    Validity and score interpretation of the 12-item Psoriatic Arthritis Impact of Disease: an analysis of pooled data from two phase 3 trials of bimekizumab in patients with psoriatic... by Laure Gossec, Ana-Maria Orbai, Maarten de Wit, Dafna D Gladman, Laura C Coates, Alexis Ogdie, Vanessa Taieb, Jeremy Lambert, Barbara Ink, Christopher G Pelligra, Valérie Ciaravino

    Published 2024-02-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Efficacy of guselkumab, a selective IL-23 inhibitor, in Preventing Arthritis in a Multicentre Psoriasis At-Risk cohort (PAMPA): protocol of a randomised, double-blind, placebo controlled multicentre trial

    Efficacy of guselkumab, a selective IL-23 inhibitor, in Preventing Arthritis in a Multicentre Psoriasis At-Risk cohort (PAMPA): protocol of a randomised, double-blind, placebo cont... by Joseph F Merola, Lihi Eder, Proton Rahman, Soumya D Chakravarty, Jose U Scher, Alexis Ogdie, Rebecca B Blank, Vincent Piguet, C T Ritchlin, Jonathan Samuels, Kun Qian, Wayne Gulliver, Ralf G Thiele, Rebecca H Haberman, Rochelle Castillo, Cinty Gong, Andrea L Neimann, Katrina A MacFarlane, Sydney Catron, Michael Toprover, Zakwan Uddin, Jiyuan Hu, Francisco Tausk, Jensen Yeung

    Published 2022-12-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Effectiveness and safety of the recombinant zoster vaccine in adult patients with systemic lupus erythematosus: a claims-based retrospective cohort study in the USA

    Effectiveness and safety of the recombinant zoster vaccine in adult patients with systemic lupus erythematosus: a claims-based retrospective cohort study in the USA by Alexis Ogdie, Michael D George, Huifeng Yun, Kristin Palmsten, Omar Ali, Cheryl N McMahill-Walraven, Aziza Jamal-Allial, Mano Selvan, Djeneba Audrey Djibo, Driss Oraichi, Sophie E Mayer, Sheryl A Kluberg, O’Mareen Spence, Harry Seifert, Andrew L Simon, Jenice S Ko, Caroline Hugh, Meg Her, Kathleen Shattuck, Kimberly Daniels, Qianli Ma, Rachel P Ogilvie, Najat Ziyadeh

    Published 2025-08-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: